{
    "organizations": [],
    "uuid": "66b826a85be2630feb3a1514b6ef4ce9d497c47d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-edwards-lifesciences-reports-q1-ea/brief-edwards-lifesciences-reports-q1-earnings-of-0-96-share-idUSB8N1LI03J",
    "ord_in_thread": 0,
    "title": "BRIEF-Edwards Lifesciences Reports Q1 Earnings Of $0.96/Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Edwards Lifesciences Corp:\n* QUARTERLY SALES $894.8 MILLION, UP 1.3 PERCENT * QUARTERLY TOTAL ADJUSTED SALES $937.5 MILLION, UP 9.3 PERCENT\n* EDWARDS LIFESCIENCES CORP Q1 EARNINGS PER SHARE VIEW $1.11, REVENUE VIEW $932.9 MILLION — THOMSON REUTERS I/B/E/S\n* QUARTERLY TRANSCATHETER HEART VALVE THERAPY SALES OF $551.6 MILLION, UP 2.3 PERCENT\n* SAYS 2018 ADJUSTED EARNINGS PER SHARE OUTLOOK RAISED TO $4.50 TO $4.70 FROM $4.43 TO $4.63\n* SAYS REMAINS CONFIDENT IN ACHIEVING HIGHER END OF 2018 SALES OUTLOOK RANGE OF $3.5 BILLION TO $3.9 BILLION\n* EDWARDS LIFESCIENCES CORP FY2018 EARNINGS PER SHARE VIEW $4.53, REVENUE VIEW $3.85 BILLION — THOMSON REUTERS I/B/E/S\n* EDWARDS LIFESCIENCES CORP Q2 EARNINGS PER SHARE VIEW $1.17, REVENUE VIEW $967.0 MILLION — THOMSON REUTERS I/B/E/S\n* SAYS FOR Q2, PROJECTS TOTAL SALES TO BE $950 MILLION TO $1 BILLION AND ADJUSTED EARNINGS PER SHARE OF $1.05 TO $1.15\n* SAYS CONTINUES TO EXPECT THVT FY UNDERLYING SALES GROWTH RATE TO BE AT HIGHER END OF 11 PERCENT TO 15 PERCENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T04:29:00.000+03:00",
    "crawled": "2018-04-25T14:22:33.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "edward",
        "lifesciences",
        "corp",
        "quarterly",
        "sale",
        "million",
        "percent",
        "quarterly",
        "total",
        "adjusted",
        "sale",
        "million",
        "percent",
        "edward",
        "lifesciences",
        "corp",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "quarterly",
        "transcatheter",
        "heart",
        "valve",
        "therapy",
        "sale",
        "million",
        "percent",
        "say",
        "adjusted",
        "earnings",
        "per",
        "share",
        "outlook",
        "raised",
        "say",
        "remains",
        "confident",
        "achieving",
        "higher",
        "end",
        "sale",
        "outlook",
        "range",
        "billion",
        "billion",
        "edward",
        "lifesciences",
        "corp",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "edward",
        "lifesciences",
        "corp",
        "q2",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "say",
        "q2",
        "project",
        "total",
        "sale",
        "million",
        "billion",
        "adjusted",
        "earnings",
        "per",
        "share",
        "say",
        "continues",
        "expect",
        "thvt",
        "fy",
        "underlying",
        "sale",
        "growth",
        "rate",
        "higher",
        "end",
        "percent",
        "percent",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}